FDA Inspection
Allergan Sales, LLCAllergan Sales, LLC – FDA Inspection, Jan 15, 2016
Record Details
This FDA Inspection record concerns Allergan Sales, LLC, with an inspection on January 15, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Allergan Sales, LLC
- Inspection Date
- January 15, 2016
- Product Type
- Drugs
View Company Profile
ID · 2f64dfbe-2bad-4efc-bff4-2ea08f4ca05f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 966871
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allergan Sales, LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Los Angeles District Office | |
| September 19, 2025 | Not classified | Los Angeles District Office | |
| October 26, 2023 | Not classified | Los Angeles District Office | |
| July 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2019 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Allergan Sales, LLC
- FDA Inspection 1285134 - 2025-11-07
- FDA Inspection 1276207 - 2025-09-19
- FDA Inspection 1226167 - 2023-10-26
- FDA Inspection 1217963 - 2023-07-28
- FDA Inspection 1077891 - 2019-01-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.